Nuveen Asset Management, LLC Abbott Laboratories Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 10,892,194 shares of ABT stock, worth $1.11 Billion. This represents 0.38% of its overall portfolio holdings.

Number of Shares

10,892,194

Previous 12,366,142 11.92%

Holding current value

$1.11 Billion

Previous $1.36 Billion 9.05%

% of portfolio

0.38%

Previous 0.45%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $161 Million - $178 Million	-1,473,948 Reduced 11.92%	10,892,194 $1.24 Billion
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $25.8 Million - $31.6 Million	286,258 Added 2.37%	12,366,142 $1.36 Billion
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $48.2 Million - $57.8 Million	-504,217 Reduced 4.01%	12,079,884 $1.17 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $52.1 Million - $58 Million	516,810 Added 4.28%	12,584,101 $1.37 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $47.7 Million - $56.1 Million	492,031 Added 4.25%	12,067,291 $1.22 Billion

Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $58.4 Million - $68.6 Million	614,693 Added 5.61%	11,575,260 $1.27 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $26.5 Million - $30.7 Million	-274,367 Reduced 2.44%	10,960,567 $1.06 Billion
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $93.4 Million - $113 Million	914,709 Added 8.86%	11,234,934 $1.22 Billion
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $131 Million - $160 Million	-1,149,088 Reduced 10.02%	10,320,225 $1.26 Billion
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $186 Million - $228 Million	1,609,489 Added 16.32%	11,469,313 $1.61 Billion
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $152 Million - $168 Million	1,304,306 Added 15.25%	9,859,824 $1.16 Billion
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $28.8 Million - $34 Million	-272,703 Reduced 3.09%	8,555,518 $992 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $59.5 Million - $70.1 Million	-546,646 Reduced 5.83%	8,828,221 $1.06 Billion
Q4 2020 May 17, 2021	SELL	$105.0 - $114.42 $1.41 Million - $1.54 Million	-13,475 Reduced 0.14%	9,374,867 $1.03 Billion
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.86 Million - $2.02 Million	17,673 Added 0.19%	9,388,342 $1.03 Billion
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $66.9 Million - $81.2 Million	-729,924 Reduced 7.23%	9,370,669 $1.02 Billion
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $30.9 Million - $39.5 Million	403,277 Added 4.16%	10,100,593 $923 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $80.4 Million - $118 Million	-1,280,522 Reduced 11.66%	9,697,316 $765 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $60.4 Million - $67.2 Million	-769,059 Reduced 6.55%	10,977,838 $954 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $51.6 Million - $56 Million	-631,047 Reduced 5.1%	11,746,897 $983 Million
Q2 2019 Aug 15, 2019	BUY	$72.88 - $85.0 $891 Million - $1.04 Billion	12,222,999 Added 7888.6%	12,377,944 $1.04 Billion
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $98,535 - $119,129	-1,488 Reduced 0.95%	154,945 $12.4 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $110,927 - $125,664	-1,692 Reduced 1.07%	156,433 $11.3 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $379,758 - $458,133	6,245 Added 4.11%	158,125 $11.6 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $1.99 Million - $2.19 Million	34,545 Added 29.44%	151,880 $9.26 Million
Q1 2018 May 14, 2018	SELL	$56.27 - $63.62 $10,128 - $11,451	-180 Reduced 0.15%	117,335 $7.03 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $37,683 - $40,343	-702 Reduced 0.59%	117,515 $0
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $5.68 Million - $6.34 Million	118,217	118,217 $6.31 Million

Others Institutions Holding ABT

# of Institutions

3,124

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Abbott Laboratories Transaction History